Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

PJ Online | News: Prime Minister defends costs of NHS cash boost

Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 268 No 7195 p557-561
27 April 2002

This article
Reprint
Photocopy


News summary

Related websites
HM Treasury (www.hm-treasury.gov.uk)


Prime Minister defends costs of NHS cash boost

The Prime Minister (Tony Blair) was forced on the defensive over the future of the National Health Service, despite a massive cash injection in last week's Budget (our Lobby correspondent writes).

Nurses and other health care professionals have protested that the Chancellor of the Exchequer's 1 per cent rise in National Insurance Contributions will cost health service and local government staff £600m. Tony Blair admitted that his Ministers had to make "hard choices", but added: "The increasing demands on the NHS have to be tackled and it cannot come for free. We have to decide as a country which is the best and fairest way to do it."

The Budget included a 43 per cent rise in NHS spending over the next five years, equivalent to £40bn (PJ, 20 April, p522). A new independent NHS auditor will for the first time report annually to Parliament and local reports will show how health money has been spent. There will be new incentives for hospitals to improve performance. The Secretary of State for Health (Alan Milburn) later outlined plans to employ 15,000 more doctors and 38,000 more nurses and build 42 new hospitals by 2008. He also plans to introduce a scheme to fund hospitals according to their results.

Derek Wanless, author of a Treasury-commissioned report into the future financing of the NHS, warned that spending forecasts are clouded by uncertainty. His report, published on 17 April, says that health costs could soar to between £154bn and £184bn by 2023, compared with the current £68bn. The Institute of Fiscal Studies has predicted that the expansion of NHS funding could force the Chancellor to introduce more tax rises on top of his Budget measures or boost borrowing by £7bn.

News feature, p564

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal

Citation: The Pharmaceutical Journal URI: 20006606

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Rate
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.